Phase III trial of androgen suppression adjuvant to definitive radiotherapy. Long term results of RTOG study 85-31.

Reviewer: Ryan Smith, MD
OncoLink
Ultima Vez Modificado: 31 de mayo del 2003

Translation for this article does not exist

Blogs

Eight Tips for Addressing Medical Billing Issues
by Christina Bach, MSW, LCSW, OSW-C
May 25, 2016